(1) In 1999, all amphetamine derivatives still sold in France as appetite suppressants were withdrawn from the market because of serious cardiovascular adverse effects. Sibutramine, marketed in France since 2001, is closely related to this group of drugs. (2) The adverse effects shared by these drugs are mainly neuropsychiatric (due to a psychostimulant action) and cardiovascular (arterial hypertension and tachycardia). (3) More specific cardiovascular adverse effects, such as pulmonary hypertension and severe cardiac valve damage, emerged after several years of use. The first reports date back to the 1960s. (4) The pulmonary hypertension associated with appetite suppressants can be fatal or necessitate transplantation. (5) Cardiac valve damage due to appetite suppressants is generally irreversible and sometimes requires surgery.
For those seeking addiction treatment for themselves or a loved one, the Amphetamines.com helpline is a private and convenient solution.
Calls to any general helpline (non-facility specific 1-8XX numbers) for your visit will be answered by American Addiction Centers (AAC), a paid advertiser on Amphetamines.com.
AAC representatives are standing by 24/7 to discuss your treatment options. These representatives work solely for AAC and will discuss whether an AAC facility may be an option for you. This helpline is offered at no cost to you and with no obligation to enter into treatment. Neither Amphetamines.com nor AAC receives any commission or other fee that is dependent upon which treatment provider a visitor may ultimately choose.
For more information on AAC’s commitment to ethical marketing and treatment practices, or to learn more about how to select a treatment provider, visit AmericanAddictionCenters.org. If you wish to explore additional treatment options or connect with a specific rehab center, you can browse top-rated listings or visit SAMHSA.